FDA's 2024 review states the mechanism of action is still unknown, which limits how confidently any specific physiological effect can be predicted in humans
doi: 10.3389/fnut.2021.780205 Received 20 September 2021 Accepted 28 October 2021 Published 25 November 2021 Volume 8 - 2021 Edited by Andree Kurniawan, University of Pelita Harapan, Indonesia Reviewed by Chandrayani Simanjorang, State Polytechnic of Nusa Utara, Indonesia
Despite strong research interest in the application of sermorelin to improve athletic performance and body composition, there are no published figures to indicate the dosage at which this peptide may be administered to this end
This IGF-1 induced effect was blocked by pre-treatment with actinomycin D (Fig
Archived from the original on December 22, 2017
Certainly, this method had been applied in many previous studies (50, 51)